OVERVIEW
Our unique Guangzhou Biotechnology Investment Fund (GIBF) creates added value for overseas companies looking to expand in China.
With years of life sciences expertise, private equity investment experience, local knowledge based on over a decade of activity in China, and numerous foreign companies already established in China, GIBF serves as an invaluable strategic investor and partner in China with a proven ability and track record of conducting multi-center clinical trials in top-tier Chinese hospitals, providing the resources and networks for securing successful NMPA submissions, commercializing products and developing manufacturing capacity to satisfy both local and global demand.
OUR STRATEGY
Enabling value creation by investing in Chinese subsidiaries of foreign companies active in the biomedical outside China
GIBF partners with selected overseas companies to establish new JVs in the Chinese market, enabling the foreign companies to control and manage their new subsidiaries as the majority shareholders.
PORTFOLIO
Companies' Overview
Partnering with top-tier international life sciences companies offering innovative solutions to Chinese healthcare needs.
OUR PEOPLE
Meet Our Management
Where global leaders in life sciences meet local talents to achieve cross-border investments and companies' formation.
Latest
News
VIEW ALL
Latest
News
